BiotechTube
Handa Pharmaceuticals

Handa Pharmaceuticals

San Francisco Bay Area, United States
handapharma.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Handa Pharma is a private, U.S.-based specialty and generic drug company operating in a commercial stage with an approved product portfolio. Its business model centers on in-licensing, developing, and commercializing complex generic and specialty therapeutics, as evidenced by its partnered products like PHYRAGO and TASCENSO ODT. The company is led by an experienced team with a track record of building successful pharmaceutical businesses. Handa's strategy appears to focus on identifying niche opportunities within the generic drug market to provide patient-friendly alternatives.

Generic Drugs

Technology Platform

Expertise in development and commercialization of complex generic and specialty pharmaceuticals, including formulation science and regulatory strategy for ANDA/505(b)(2) pathways.

Opportunities

The growing demand for cost-effective generic drugs, especially complex generics with higher barriers to entry, presents a significant opportunity.
Focusing on patient-friendly formulations (like ODT) for existing medications can address adherence issues and capture market share in niche therapeutic areas.

Risk Factors

The company faces intense competition and pricing pressure in the generic drug market, along with regulatory hurdles and potential patent litigation from originator companies.
Its reliance on a limited product portfolio and partnerships introduces concentration and execution risk.

Competitive Landscape

Handa competes in the crowded generic pharmaceuticals sector, dominated by large players like Teva, Sandoz, and Mylan. Its differentiation strategy relies on focusing on complex, specialty generics, competing with other niche specialty pharma and generic companies that target technically challenging products with fewer competitors.

More companies in Small Molecule Drugs →More companies in United States →